{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:18:00Z","timestamp":1790878680696,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012464","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T00:00:00Z","timestamp":1535068800000}}],"reference-count":161,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012464.pub2","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T11:45:39Z","timestamp":1535111139000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations"],"prefix":"10.1002","volume":"2018","author":[{"given":"George U","family":"Eleje","sequence":"first","affiliation":[{"name":"Faculty of Medicine, College of Health Sciences, Nnamdi Azikiwe University, Nnewi Campus; Effective Care Research Unit, Department of Obstetrics and Gynaecology; PMB 5001, Nnewi Anambra State Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahizechukwu C","family":"Eke","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine; Division of Maternal Fetal Medicine, Department of Gynecology and Obstetrics; 600 N Wolfe Street Phipps 228 Baltimore Maryland USA 21287-1228"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifeanyichukwu U","family":"Ezebialu","sequence":"additional","affiliation":[{"name":"Faculty of Clinical medicine, College of Medicine, Anambra State University Amaku; Department of Obstetrics and Gynaecology; Awka Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph I","family":"Ikechebelu","sequence":"additional","affiliation":[{"name":"Nnamdi Azikiwe University Teaching Hospital; Department of Obstetrics\/Gynaecology; Nnewi Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel O","family":"Ugwu","sequence":"additional","affiliation":[{"name":"University of Nigeria Enugu Campus\/University of Nigeria Teaching Hospital Ituko-Ozalla; Obstetrics and Gynaecology; Enugu Nigeria 400001"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onyinye O","family":"Okonkwo","sequence":"additional","affiliation":[{"name":"Tabitha Medical Centre; Department of Pathology; Abuja Nigeria 400001"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,8,24]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","article-title":"Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study","volume":"7","author":"Domchek","year":"2006","journal-title":"Lancet Oncology"},{"issue":"9","key":"10.1002\/14651858.CD012464.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD012464.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"pii: djv033","DOI":"10.1093\/jnci\/djv033","article-title":"Breast cancer risk after salpingo-oophorectomy in healthy BRCA1\/2 mutation carriers: revisiting the evidence for risk reduction","volume":"107","author":"Heemskerk-Gerritsen","year":"2015","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10549-013-2765-x","article-title":"Risk-reducing surgery increases survival in BRCA1\/2 mutation carriers unaffected at time of family referral","volume":"142","author":"Ingham","year":"2013","journal-title":"Breast Cancer Research and Treatment"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"pii: djw177","DOI":"10.1093\/jnci\/djw177","article-title":"Bilateral oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers","volume":"109","author":"Kotsopoulos","year":"2017","journal-title":"Journal of the National Cancer Institute"},{"issue":"34","key":"10.1002\/14651858.CD012464.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.1200\/JCO.2005.02.9199","article-title":"Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers","volume":"23","author":"Kramer","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1200\/JCO.2006.07.4922","article-title":"Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1\/2 mutation carriers","volume":"25","author":"Madalinska","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"17","key":"10.1002\/14651858.CD012464.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","article-title":"Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers","volume":"91","author":"Rebbeck","year":"1999","journal-title":"Journal of the National Cancer Institute"},{"issue":"21","key":"10.1002\/14651858.CD012464.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012464.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"22","author":"Rebbeck","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD012464.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/13697130902780846","article-title":"Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy","volume":"12","author":"Benshushan","year":"2009","journal-title":"Climacteric"},{"issue":"4","key":"10.1002\/14651858.CD012464.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1158\/1055-9965.EPI-06-0829","article-title":"Age at menarche and menopause and breast cancer risk in the International BRCA1\/2 Carrier Cohort Study","volume":"16","author":"Chang-Claude","year":"2007","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"30","key":"10.1002\/14651858.CD012464.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study","volume":"23","author":"Eisen","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"10.1002\/14651858.CD012464.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/ejhg.2009.60","article-title":"Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk","volume":"17","author":"Evans","year":"2009","journal-title":"European Journal of Human Genetics"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-013-2583-1","article-title":"Contralateral mastectomy improves survival in women with BRCA1\/2-associated breast cancer","volume":"140","author":"Evans","year":"2013","journal-title":"Breast Cancer Research and Treatment"},{"issue":"2","key":"10.1002\/14651858.CD012464.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-0004.2008.01117.x","article-title":"Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene","volume":"75","author":"Finch","year":"2009","journal-title":"Clinical Genetics"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygyno.2010.12.326","article-title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation","volume":"121","author":"Finch","year":"2011","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/pon.2041","article-title":"The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation","volume":"22","author":"Finch","year":"2013","journal-title":"Psycho-oncology"},{"issue":"15","key":"10.1002\/14651858.CD012464.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1002\/14651858.CD012464.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1200\/JCO.2011.37.8133","article-title":"Breast and ovarian cancer risk and risk reduction in Jewish BRCA1\/2 mutation carriers","volume":"30","author":"Finkelman","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD012464.pub2-BIB0022|cit22","first-page":"2029","article-title":"Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis","volume":"24","author":"Heemskerk-Gerritsen","year":"2013","journal-title":"Journal of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ijc.29032","article-title":"Improved overall survival after contralateral risk-reducing mastectomy in BRCA1\/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis","volume":"136","author":"Heemskerk-Gerritsen","year":"2015","journal-title":"International Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.anplas.2016.02.002","article-title":"A new strategy for prophylactic surgery in BRCA women: combined mastectomy and laparoscopic salpingo-oophorectomy with immediate reconstruction by double DIEP flap","volume":"61","author":"Hunsinger","year":"2016","journal-title":"Annales de Chirurgie Plastique et Esthetique"},{"issue":"2","key":"10.1002\/14651858.CD012464.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5152\/jtgga.2016.15223","article-title":"Primary peritoneal cancer in BRCA carriers after prophylactic bilateral salpingo-oophorectomy","volume":"17","author":"Iavazzo","year":"2016","journal-title":"Journal of the Turkish German Gynecological Association"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ygyno.2015.11.016","article-title":"Sexual activity and functioning after risk-reducing salpingo-oophorectomy: impact of hormone replacement therapy","volume":"140","author":"Johansen","year":"2016","journal-title":"Gynecologic Oncology"},{"issue":"5","key":"10.1002\/14651858.CD012464.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/aogs.13120","article-title":"Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy","volume":"96","author":"Johansen","year":"2017","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"21","key":"10.1002\/14651858.CD012464.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD012464.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3182783c2f","article-title":"Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers","volume":"121","author":"Kwon","year":"2013","journal-title":"Obstetrics and Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD012464.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/cncr.22603","article-title":"Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation","volume":"109","author":"Laki","year":"2007","journal-title":"Cancer"},{"issue":"28","key":"10.1002\/14651858.CD012464.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1200\/JCO.2005.02.626","article-title":"Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer","volume":"23","author":"Madalinska","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD012464.pub2-BIB0033|cit33","first-page":"814","article-title":"Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status","volume":"118","author":"Manchanda","year":"2011","journal-title":"International Journal of Obstetrics and Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","article-title":"Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation","volume":"345","author":"Meijers-Heijboer","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13048-016-0220-4","article-title":"Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers","volume":"9","author":"Menkiszak","year":"2016","journal-title":"Journal of Ovarian Research"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"g226","DOI":"10.1136\/bmj.g226","article-title":"Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis","volume":"348","author":"Metcalfe","year":"2014","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD012464.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jmig.2017.03.001","article-title":"The role of routine peritoneal and omental biopsies at risk reducing salpingo-oophorectomy","volume":"24","author":"Miller","year":"2017","journal-title":"Journal of Minimally Invasive Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD012464.pub2-BIB0038|cit38","first-page":"1325","article-title":"Prophylactic mastectomy with immediate reconstruction combined with simultaneous laparoscopic salpingo-oophorectomy via a transmammary route: a novel surgical approach to female BRCA-mutation carriers","volume":"289","author":"Perabo","year":"2014","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"5","key":"10.1002\/14651858.CD012464.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"International Journal of Gynecological Cancer"},{"issue":"10","key":"10.1002\/14651858.CD012464.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1470-2045(06)70869-5","article-title":"Survival patterns after oophorectomy in premenopausal women: a population-based cohort study","volume":"7","author":"Rocca","year":"2006","journal-title":"Lancet Oncology"},{"issue":"14","key":"10.1002\/14651858.CD012464.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/95.14.1072","article-title":"Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study","volume":"95","author":"Rutter","year":"2003","journal-title":"Journal of the National Cancer Institute"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD012464.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/01.AOG.0000228959.30577.13","article-title":"Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations","volume":"108","author":"Schmeler","year":"2006","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD012464.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1399-0004.2010.01604.x","article-title":"Breast cancer after bilateral risk-reducing mastectomy","volume":"79","author":"Skytte","year":"2011","journal-title":"Clinical Genetics"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0044|cit44","first-page":"33","article-title":"Prophylactic oophorectomy in inherited breast\/ovarian cancer families","volume":"17","author":"Struewing","year":"1995","journal-title":"Journal of the National Cancer Institute. Monographs"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bjc.6602703","article-title":"Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers","volume":"93","author":"Sprundel","year":"2005","journal-title":"British Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/13697137.2017.1285879","article-title":"Impact of risk-reducing salpingo-oophorectomy in premenopausal women","volume":"20","author":"Vermeulen","year":"2017","journal-title":"Climacteric"},{"issue":"4","key":"10.1002\/14651858.CD012464.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3181a106d4","article-title":"ACOG Practice Bulletin No. 103: hereditary breast and ovarian cancer syndrome","volume":"113","author":"American College of Obstetricians and Gynecologists","year":"2009","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0048|cit48","doi-asserted-by":"crossref","unstructured":"Agoritsas T Guyatt GH Evidence-based medicine 20 years on: a view from the inside Canadian Journal of Neurological Sciences 2013 448 9","DOI":"10.1017\/S0317167100014499"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10549-017-4635-4","article-title":"High prevalence of deleterious BRCA1 and BRCA2 germline mutations in Arab breast and ovarian cancer patients","volume":"168","author":"Alhuqail","year":"2018","journal-title":"Breast Cancer Research and Treatment"},{"issue":"4","key":"10.1002\/14651858.CD012464.pub2-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007697.pub2","article-title":"Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer","author":"Ang","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12935-017-0401-2","article-title":"Transactivation of the estrogen receptor promoter by BRCA1","volume":"17","author":"Archey","year":"2017","journal-title":"Cancer Cell International"},{"issue":"6","key":"10.1002\/14651858.CD012464.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1200\/JCO.2004.06.090","article-title":"Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1\/2 mutations: a decision analysis","volume":"22","author":"Armstrong","year":"2004","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejca.2016.03.009","article-title":"Germline BRCA1\/2 mutation testing is indicated in every patient with epithelial ovarian cancer: a systematic review","volume":"61","author":"Arts-de Jong","year":"2016","journal-title":"European Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD012464.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/0284186X.2017.1404635","article-title":"Accuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer","volume":"57","author":"Augustinsson","year":"2018","journal-title":"Acta Oncologica"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0055|cit55","unstructured":"Barlin J Pike M Otegbeye E Arnold A Stadler Z Robson M Does postmenopausal risk-reducing salpingo-oophorectomy reduce the risk of BRCA-associated breast cancer? Proceedings of the 2013 Society of Gynecologic Oncology (SGO) Annual Meeting on Women\u2019s Cancer; 2013 March 9-12; Los Angeles (CA) 2013 Abstract 245"},{"issue":"16","key":"10.1002\/14651858.CD012464.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/94.16.1221","article-title":"On the use of familial aggregation in population-based case probands for calculating penetrance","volume":"94","author":"Begg","year":"2002","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3332\/ecancer.2016.639","article-title":"Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival","volume":"10","author":"Biglia","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12885-015-2011-5","article-title":"The lack of clinical value of peritoneal washing cytology in high risk patients undergoing risk-reducing salpingo-oophorectomy: a retrospective study and review","volume":"16","author":"Blok","year":"2016","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/jsm.12713","article-title":"Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention","volume":"12","author":"Bober","year":"2015","journal-title":"Journal of Sexual Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ijc.20429","article-title":"Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature","volume":"112","author":"Calderon-Margalit","year":"2004","journal-title":"International Journal of Cancer"},{"issue":"25","key":"10.1002\/14651858.CD012464.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1002\/14651858.CD012464.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008273.pub2","article-title":"Information interventions for orienting patients and their carers to cancer care facilities","author":"Chan","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Current Opinion in Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0064|cit64","unstructured":"National Institutes of Health - National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03 evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf"},{"issue":"9","key":"10.1002\/14651858.CD012464.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1245\/s10434-015-4532-1","article-title":"Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis","volume":"22","author":"Felice","year":"2015","journal-title":"Annals of Surgical Oncology"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2017.09.005","article-title":"Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: an evidence-based approach on what women should know","volume":"61","author":"Felice","year":"2017","journal-title":"Cancer Treatment Reviews"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0067|cit67","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch15","volume-title":"Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-analysis","author":"Deeks","year":"2001"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/GCO.0b013e32801195da","article-title":"Prophylactic oophorectomy in women at increased cancer risk","volume":"19","author":"Domchek","year":"2007","journal-title":"Current Opinion in Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD012464.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.ajog.2004.04.028","article-title":"Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy","volume":"191","author":"Dowdy","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD012464.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12325-016-0281-1","article-title":"Selecting patients with ovarian cancer for germline BRCA mutation testing: findings from guidelines and a systematic literature review","volume":"33","author":"Eccles","year":"2016","journal-title":"Advances in Therapy"},{"issue":"S6","key":"10.1002\/14651858.CD012464.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"vi24","DOI":"10.1093\/annonc\/mdt333","article-title":"Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Ledermann","year":"2013","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejca.2014.11.022","article-title":"Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer","volume":"51","author":"Fakkert","year":"2015","journal-title":"European Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"American Journal of Human Genetics"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"787143","DOI":"10.1155\/2014\/787143","article-title":"BRCA-associated ovarian cancer: from molecular genetics to risk management","volume":"2014","author":"Girolimetti","year":"2014","journal-title":"BioMed Research International"},{"issue":"10","key":"10.1002\/14651858.CD012464.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/aogs.12948","article-title":"Ovarian and tubal cancer in Denmark: an update on incidence and survival","volume":"95","author":"Gottschau","year":"2016","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0077|cit77","unstructured":"GRADE Working Group, McMaster University GRADEpro Guideline Development Tool (GDT) 2014"},{"issue":"5","key":"10.1002\/14651858.CD012464.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/13697137.2016.1209396","article-title":"Hormone therapy after prophylactic risk-reducing bilateral salpingo-oophorectomy in women who have BRCA gene mutation","volume":"19","author":"Guidozzi","year":"2016","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12885-015-1597-y","article-title":"Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study","volume":"15","author":"Harmsen","year":"2015","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1002\/14651858.CD012464.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/AOG.0000000000001448","article-title":"Salpingectomy with delayed oophorectomy in BRCA1\/2 mutation carriers: estimating ovarian cancer risk","volume":"127","author":"Harmsen","year":"2016","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD012464.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/302320","article-title":"The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews","volume":"64","author":"Hartge","year":"1999","journal-title":"American Journal of Human Genetics"},{"issue":"13","key":"10.1002\/14651858.CD012464.pub2-BIB0082|cit82","first-page":"1271","article-title":"Atypical hyperplasia of the breast","volume":"372","author":"Hartmann","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"24","key":"10.1002\/14651858.CD012464.pub2-BIB0083|cit83","first-page":"2404","article-title":"Risk-reducing surgery in hereditary breast and ovarian cancer","volume":"374","author":"Hartmann","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD012464.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjc.6603725","article-title":"No efficacy of annual gynaecological screening in BRCA1\/2 mutation carriers; an observational follow-up study","volume":"96","author":"Hermsen","year":"2007","journal-title":"British Journal of Cancer"},{"issue":"7414","key":"10.1002\/14651858.CD012464.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0086|cit86","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD012464.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.cellbi.2008.01.007","article-title":"Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast","volume":"32","author":"Hussein","year":"2008","journal-title":"Cell Biology International"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0088|cit88","unstructured":"International Agency for Research on Cancer World Health Organization GLOBOCAN 2012: estimated cancer incidence, and mortality and prevalence worldwide in 2012 globocan.iarc.fr\/Pages\/fact_sheets_population.aspx"},{"issue":"12","key":"10.1002\/14651858.CD012464.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ejca.2010.04.018","article-title":"Oral contraceptive use and breast or ovarian cancer risk in BRCA1\/2 carriers: a meta-analysis","volume":"46","author":"Iodice","year":"2010","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fonc.2016.00119","article-title":"Ovarian cancer and BRCA1\/2 testing: opportunities to improve clinical care and disease prevention","volume":"6","author":"Karakasis","year":"2016","journal-title":"Frontiers in Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012464.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ygyno.2003.12.009","article-title":"Defining cancer risks for BRCA germline mutation carriers: implications for surgical prophylaxis","volume":"92","author":"Karlan","year":"2004","journal-title":"Gynecologic Oncology"},{"issue":"5645","key":"10.1002\/14651858.CD012464.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"issue":"13","key":"10.1002\/14651858.CD012464.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/jnci\/95.13.941","article-title":"Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation","volume":"95","author":"Klaren","year":"2003","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0094|cit94","doi-asserted-by":"crossref","unstructured":"Koc N Ayas S Arinkan SA Comparison of the classical method and SEE-FIM protocol in detecting microscopic lesions in fallopian tubes with gynecological lesions Journal of Pathology and Translational Medicine 2018 21 7 10.4132\/jptm.2016.06.17","DOI":"10.4132\/jptm.2016.06.17"},{"issue":"2","key":"10.1002\/14651858.CD012464.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-016-3685-3","article-title":"Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study","volume":"155","author":"Kotsopoulos","year":"2016","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.0211","article-title":"Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers","volume":"[Epub ahead of","author":"Kotsopoulos","journal-title":"JAMA oncology"},{"issue":"9","key":"10.1002\/14651858.CD012464.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"E391","DOI":"10.1503\/cmaj.109-4475","article-title":"Mixed reviews on removing fallopian tubes to prevent ovarian cancer","volume":"185","author":"Kramer","year":"2013","journal-title":"Canadian Medical Association Journal"},{"issue":"23","key":"10.1002\/14651858.CD012464.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/2046-4053-2-81","article-title":"Assessing and presenting summaries of evidence in Cochrane Reviews","volume":"2","author":"Langendam","year":"2013","journal-title":"Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.3802\/jgo.2017.28.e3","article-title":"Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers","volume":"28","author":"Lee","year":"2017","journal-title":"Journal of Gynecologic Oncology"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2017.07.004","article-title":"Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers","volume":"84","author":"Lee","year":"2017","journal-title":"European Journal of Cancer"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ygyno.2012.12.006","article-title":"Serial sectioning of the fallopian tube allows for improved identification of primary fallopian tube carcinoma","volume":"129","author":"Lengyel","year":"2013","journal-title":"Gynecologic Oncology"},{"issue":"5","key":"10.1002\/14651858.CD012464.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/PGP.0b013e318216d447","article-title":"p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary","volume":"30","author":"Leonhardt","year":"2011","journal-title":"International Journal of Gynecological Pathology"},{"issue":"15","key":"10.1002\/14651858.CD012464.pub2-BIB0104|cit104","first-page":"3197","article-title":"Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis","volume":"58","author":"Leygue","year":"1998","journal-title":"Cancer Research"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ygyno.2015.10.010","article-title":"Germline BRCA1\/2 testing practices in ovarian cancer: current state and opportunities for new directions","volume":"140","author":"Lheureux","year":"2016","journal-title":"Gynecologic Oncology"},{"issue":"15","key":"10.1002\/14651858.CD012464.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1158\/1078-0432.CCR-15-1465","article-title":"Effectiveness of prophylactic surgeries in BRCA1 or BRCA2 mutation carriers: a meta-analysis and systematic review","volume":"22","author":"Li","year":"2016","journal-title":"Clinical Cancer Research"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD012464.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<310::AID-CNCR15>3.0.CO;2-W","article-title":"Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes","volume":"83","author":"Loman","year":"1998","journal-title":"Cancer"},{"issue":"11","key":"10.1002\/14651858.CD012464.pub2-BIB0109|cit109","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002748.pub3","article-title":"Prophylactic mastectomy for the prevention of breast cancer","author":"Lostumbo","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012464.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.amjsurg.2016.06.010","article-title":"Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review","volume":"212","author":"Ludwig","year":"2016","journal-title":"American Journal of Surgery"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD012464.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"viii83","DOI":"10.1093\/annonc\/mdt313","article-title":"Hereditary ovarian and breast cancer: what have we learned?","volume":"24","author":"Lynch","year":"2013","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012464.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4048\/jbc.2016.19.2.218","article-title":"Experience with bilateral risk-reducing mastectomy for an unaffected BRCA mutation carrier","volume":"19","author":"Maeshima","year":"2016","journal-title":"Journal of Breast Cancer"},{"issue":"4","key":"10.1002\/14651858.CD012464.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/PGP.0b013e318264ae09","article-title":"Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the \"sectioning and extensively examining the FIMbriated end\" (SEE-FIM) protocol?","volume":"32","author":"Mahe","year":"2013","journal-title":"International Journal of Gynecological Pathology"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12905-014-0150-5","article-title":"Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers","volume":"14","author":"Marchetti","year":"2014","journal-title":"BMC Women's Health"},{"issue":"7","key":"10.1002\/14651858.CD012464.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/1055-9965.EPI-16-0011","article-title":"Parity and oral contraceptive use in relation to ovarian cancer risk in older women","volume":"25","author":"McGuire","year":"2016","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/2046-4053-3-82","article-title":"A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation","volume":"3","author":"Meader","year":"2014","journal-title":"Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ogc.2013.05.009","article-title":"Hereditary breast\/ovarian cancer syndrome: a primer for obstetricians\/gynaecologists","volume":"40","author":"Meaney-Delman","year":"2013","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaoncol.2015.0658","article-title":"Effect of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"1","author":"Metcalfe","year":"2015","journal-title":"JAMA Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1383-5742(03)00016-4","article-title":"Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism","volume":"544","author":"Mitrunen","year":"2003","journal-title":"Mutation Research"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1749-6632.2001.tb02726.x","article-title":"Hormonal prevention of hereditary breast cancer","volume":"952","author":"Narod","year":"2001","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0121|cit121","unstructured":"National Comprehensive Cancer Network Epithelial ovarian cancer (including fallopian tube cancer and primary peritoneal cancer) Version 3.2014. NCCN Clinical Practice Guidelines in Oncology www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#site"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ygyno.2018.04.564","article-title":"Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: a pilot study in women with BRCA1\/2 mutations","volume":"150","author":"Nebgen","year":"2018","journal-title":"Gynecologic Oncology"},{"issue":"4","key":"10.1002\/14651858.CD012464.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.suronc.2015.09.008","article-title":"Prophylactic salpingectomy and prophylactic salpingoophorectomy for adnexal high-grade serous epithelial carcinoma: a reappraisal","volume":"24","author":"Oliver Perez","year":"2015","journal-title":"Surgical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD012464.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6601692","article-title":"Clinical outcome of prophylactic oophorectomy in BRCA1\/BRCA2 mutation carriers and events during follow-up","volume":"90","author":"Olivier","year":"2004","journal-title":"British Journal of Cancer"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012464.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/j.1524-4741.2004.101S3.x","article-title":"Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations","volume":"10","author":"Olopade","year":"2004","journal-title":"Breast Journal"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD012464.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"v181","DOI":"10.1093\/annonc\/mdj978","article-title":"Challenges for chemotherapy in ovarian cancer","volume":"17","author":"Ozols","year":"2006","journal-title":"Annals of Oncology"},{"issue":"12","key":"10.1002\/14651858.CD012464.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"issue":"24","key":"10.1002\/14651858.CD012464.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"9","key":"10.1002\/14651858.CD012464.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/ijc.27909","article-title":"Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial","volume":"132","author":"Pinsky","year":"2013","journal-title":"International Journal of Cancer"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012464.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygyno.2014.01.018","article-title":"Risk reducing salpingo-oophorectomy for BRCA mutation carriers: twenty years later","volume":"132","author":"Powell","year":"2014","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012464.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1524-4741.2010.01055.x","article-title":"Cancer risk management decisions of women with BRCA1 or BRCA2 variants of uncertain significance","volume":"17","author":"Ready","year":"2011","journal-title":"Breast Journal"},{"issue":"31","key":"10.1002\/14651858.CD012464.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012464.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0135|cit135","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"3","key":"10.1002\/14651858.CD012464.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"American Journal of Human Genetics"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/annonc\/12.suppl_3.S3","article-title":"Quality of life as a primary end point in oncology","volume":"12 Suppl 3","author":"Roila","year":"2001","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1200\/JCO.2011.39.7638","article-title":"Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule","volume":"31","author":"Rosenthal","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"Abstract 5507","DOI":"10.1200\/jco.2013.31.15_suppl.5507","article-title":"Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2). 2013 ASCO annual meeting","volume":"(Suppl)","author":"Rosenthal","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1472-6874-10-28","article-title":"Risk-reducing strategies for women carrying BRCA1\/2 mutations with a focus on prophylactic surgery","volume":"10","author":"Salhab","year":"2010","journal-title":"BMC Women's Health"},{"issue":"12","key":"10.1002\/14651858.CD012464.pub2-BIB0141|cit141","first-page":"3776","article-title":"Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations","volume":"8","author":"Satagopan","year":"2002","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10.1002\/14651858.CD012464.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/jnci\/djx159","article-title":"Risk of serous endometrial carcinoma in women with pathogenic BRCA1\/2 variant after risk-reducing salpingo-oophorectomy","volume":"110","author":"Saule","year":"2018","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fonc.2014.00021","article-title":"Prophylactic bilateral salpingectomy as a prevention strategy in women at high-risk of ovarian cancer: a mini-review","volume":"4","author":"Schenberg","year":"2014","journal-title":"Frontiers in Oncology"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0144|cit144","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2013.03.027","article-title":"The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study","volume":"130","author":"Segev","year":"2013","journal-title":"Gynecologic Oncology"},{"issue":"11","key":"10.1002\/14651858.CD012464.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/jamaoncol.2016.1820","article-title":"Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations","volume":"2","author":"Shu","year":"2016","journal-title":"JAMA Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/sim.4780030106","article-title":"A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias","volume":"3","author":"Simon","year":"1984","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012464.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12905-017-0370-6","article-title":"The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic review","volume":"17","author":"Siyam","year":"2017","journal-title":"BMC Women's Health"},{"issue":"12","key":"10.1002\/14651858.CD012464.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0021-9681(81)90058-8","article-title":"Measuring the quality of life of cancer patients: a concise QL-index for use by physicians","volume":"34","author":"Spitzer","year":"1981","journal-title":"Journal of Chronic Diseases"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0150|cit150","doi-asserted-by":"crossref","DOI":"10.5772\/52888","article-title":"Chapter 14: PARP inhibitors in ovarian cancer","volume-title":"Ovarian Cancer - a Clinical and Translational Update","author":"Staples","year":"2013"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"24","key":"10.1002\/14651858.CD012464.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1200\/JCO.2005.05.097","article-title":"Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system","volume":"23","author":"Stirling","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"20","key":"10.1002\/14651858.CD012464.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012464.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1634\/theoncologist.2016-0444","article-title":"Risk-reducing strategies for ovarian cancer in BRCA mutation carriers: a balancing act","volume":"22","author":"Tschernichovsky","year":"2017","journal-title":"Oncologist"},{"issue":"12","key":"10.1002\/14651858.CD012464.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1471-4914(02)02434-6","article-title":"The relationship between the roles of BRCA genes in DNA repair and cancer predisposition","volume":"8","author":"Tutt","year":"2002","journal-title":"Trends in Molecular Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012464.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4161\/cbt.27628","article-title":"Lower mitotic activity in BRCA1\/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy","volume":"15","author":"Verschuer","year":"2014","journal-title":"Cancer Biology & Therapy"},{"issue":"6178","key":"10.1002\/14651858.CD012464.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1126\/science.1252230","article-title":"Cancer suppression by the chromosome custodians, BRCA1 and BRCA2","volume":"343","author":"Venkitaraman","year":"2014","journal-title":"Science"},{"key":"10.1002\/14651858.CD012464.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2407-5-70","article-title":"Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases","volume":"5","author":"Veronesi","year":"2005","journal-title":"BMC Cancer"},{"issue":"16","key":"10.1002\/14651858.CD012464.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/djh229","article-title":"Bias in intervention studies that enrol patients from high-risk clinics","volume":"96","author":"Wacholder","year":"2004","journal-title":"Journal of the National Cancer Institute"},{"issue":"13","key":"10.1002\/14651858.CD012464.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/cncr.29321","article-title":"Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer","volume":"121","author":"Walker","year":"2015","journal-title":"Cancer"},{"issue":"2","key":"10.1002\/14651858.CD012464.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2016.08.336","article-title":"Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers","volume":"143","author":"Zakhour","year":"2016","journal-title":"Gynecologic Oncology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012464.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:17:18Z","timestamp":1788315438000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012464.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,24]]},"references-count":161,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012464.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,24]]}}}